Life Sciences

Edwards acquires 2 firms in deals totaling $1.2 billion

The acquisitions by Edwards of JenaValve Technology and Endotronics come as the ...

Europe risks a setback for Eisai and Biogen’s Alzheimer...

Regulatory authorities in the European Union have declined to approve Eisai and ...

Ventyx’s Crohn’s Disease Medicine Fails to Make a Mark ...

In a phase 2 experiment, the Crohn’s disease medication developed by Ventyx Bios...

Netherlands to Get EU Green Light For $2.2B Nuclear Rea...

The Dutch government is on the verge of obtaining approval from the European Uni...

Pfizer’s Hemophilia Gene Treatment Reaches Late-Stage R...

An experimental gene therapy from Pfizer performed well in a Phase 3 trial invol...

Brazil Curbs Poultry Exports Amid Newcastle Viral Disease

Brazil has restricted its exports of chicken meat and eggs to 44 nations after t...

Ionis Plans to Advance Angelman drug Biogen with clinic...

Ionis Pharmaceuticals is set to advance one of its drugs for Angelman syndrome t...

AstraZeneca Grows EGFR Portfolio with $45M Pinetree Deal

Pinetree Therapeutics, a biotechnology firm focused on developing targeted prote...

RSV Antibody Passes Final Trials in Win for Merck

Merck & Co. hope to become the latest company to gain approval for a drug to ave...

Scorpion Secures $150M in Series C Funding to Expand Ca...

Scorpion Therapeutics has raised $150M to strengthen its clinical pipeline by ad...

House Committee Orders FDA to Halt Regulation Governing...

The FDA has been instructed by lawmakers to halt the implementation of its final...

Sionna Pens Deal With AbbVie For Cystic Fibrosis Drugs

Sionna Therapeutics has swiftly found a way to put part of its $182 million seri...

Meilleur Technologies, Creator of PET Tests for Alzheim...

With the acquisition of Meilleur Technologies, Lantheus is expanding its portfol...

Covid Symptoms Prevented by New Drug Used on Mice, No R...

Research findings from new studies show that organ damage resulting from Covid-1...

Backed by Novo Holdings, Asceneuron Raises $100 Million...

Alzheimer’s drugs have been flooding the market lately, as investors look for th...

Autoimmune-Stricken Patients Respond to Allogeneic CAR-...

Three patients with autoimmune disorders have responded favorably to allogeneic ...